| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |